F&P Healthcare: don’t mention the tariffs!

F&P Healthcare: don’t mention the tariffs!
F&P Healthcare CEO Lewis Gradon - playing the long game (Image: Supplied)
Pattrick Smellie
Fisher & Paykel Healthcare senior leaders were keeping their heads down on the potential impact of US tariffs on its business during an investors’ call on the company’s stellar half-year results.“We really don't want to be drawn into any speculation on that whatsoever,” said managing director and chief executive, Lewis Gradon.However, there were hints that its newly opened Chinese plant is unlikely to be sending products to the US, since the Guangzhou facility is primarily expected to service the Chinese mar...

More Markets

Bulls, bears and analysis …
Opinion

Simon Robertson: Bulls, bears and analysis …

Why price-to-earnings ratios don’t cut it.

Simon Robertson 15 Nov 2025
NZ stocks take Wall Street lead to end down 1%
Markets Market Close

NZ stocks take Wall Street lead to end down 1%

The S&P/NZX 50 Index closed down 133.41 points or 0.98% at 13,464.46.

Jamie Gray 14 Nov 2025
Zoono says it knows no reason for share price surge, halt lifted
Markets

Zoono says it knows no reason for share price surge, halt lifted

A trading halt granted by the ASX to Australian-listed New Zealand antimicrobials manufacturer Zoono on Wednesday after a price query has been lifted after the company said it knew of no reason for its share price soaring.Its share price rose from 0.09c to 0.18c on volumes much h...

Denise McNabb 14 Nov 2025